Economics and financing of vaccines for diarrheal diseases

References

• Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2197 - 223; http://dx.doi.org/10.1016/S0140-6736(12)61689-4; PMID: 23245608
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095 - 128; http://dx.doi.org/10.1016/S0140-6736(12)61728-0; PMID: 23245604
   PubMed Web of Science ®Google Scholar
• Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, et al, Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379:2151 - 61; http://dx.doi.org/10.1016/S0140-6736(12)60560-1; PMID: 22579125
   PubMed Web of Science ®Google Scholar
• Fischer Walker CL, Sack D, Black RE. Etiology of diarrhea in older children, adolescents and adults: a systematic review. PLoS Negl Trop Dis 2010; 4:e768; http://dx.doi.org/10.1371/journal.pntd.0000768; PMID: 20689809
   PubMed Web of Science ®Google Scholar
• Clemens J. Evaluation of vaccines against enteric infections: a clinical and public health research agenda for developing countries. Philos Trans R Soc Lond B Biol Sci 2011; 366:2799 - 805; http://dx.doi.org/10.1098/rstb.2011.0033; PMID: 21893543
   PubMed Web of Science ®Google Scholar
• Gulland A. Simple measures could prevent more than two million child deaths from pneumonia and diarrhoea. BMJ 2012; 344:e4025; http://dx.doi.org/10.1136/bmj.e4025; PMID: 22685178
   PubMedGoogle Scholar
• Lee BY, Burke DS. Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles. Vaccine 2010; 28:2806 - 9; http://dx.doi.org/10.1016/j.vaccine.2009.09.047; PMID: 19782109
   PubMed Web of Science ®Google Scholar
• Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med 2009; 361:1776 - 85; http://dx.doi.org/10.1056/NEJMra0804575; PMID: 19864676
   PubMed Web of Science ®Google Scholar
• Patel MM, Hall AJ, Vinjé J, Parashar UD. Noroviruses: a comprehensive review. J Clin Virol 2009; 44:1 - 8; http://dx.doi.org/10.1016/j.jcv.2008.10.009; PMID: 19084472
   PubMed Web of Science ®Google Scholar
• Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. Foodborne illness acquired in the United States--major pathogens. Emerg Infect Dis 2011; 17:7 - 15; http://dx.doi.org/10.3201/eid1701.P11101; PMID: 21192848
   PubMed Web of Science ®Google Scholar
• Thomas MK, Murray R, Flockhart L, Pintar K, Pollari F, Fazil A, Nesbitt A, Marshall B. Estimates of the burden of foodborne illness in Canada for 30 specified pathogens and unspecified agents, circa 2006. Foodborne Pathog Dis 2013; 10:639 - 48; http://dx.doi.org/10.1089/fpd.2012.1389; PMID: 23659355
   PubMed Web of Science ®Google Scholar
• Ruzante JM, Majowicz SE, Fazil A, Davidson VJ. Hospitalization and deaths for select enteric illnesses and associated sequelae in Canada, 2001-2004. Epidemiol Infect 2011; 139:937 - 45; http://dx.doi.org/10.1017/S0950268810001883; PMID: 20731884
   PubMed Web of Science ®Google Scholar
• Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, Hunter PR, Gray JJ, Letley LH, Rait G, Tompkins DS, et al, IID2 Study Executive Committee. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 2012; 61:69 - 77; http://dx.doi.org/10.1136/gut.2011.238386; PMID: 21708822
   PubMed Web of Science ®Google Scholar
• Werber D, Hille K, Frank C, Dehnert M, Altmann D, Müller-Nordhorn J, Koch J, Stark K. Years of potential life lost for six major enteric pathogens, Germany, 2004-2008. Epidemiol Infect 2013; 141:961 - 8; http://dx.doi.org/10.1017/S0950268812001550; PMID: 22813426
   PubMed Web of Science ®Google Scholar
• Verhoef L, Koopmans M, VAN Pelt W, Duizer E, Haagsma J, Werber D, VAN Asten L, Havelaar A. The estimated disease burden of norovirus in The Netherlands. Epidemiol Infect 2013; 141:496 - 506; http://dx.doi.org/10.1017/S0950268812000799; PMID: 22595489
   PubMed Web of Science ®Google Scholar
• Lopman BA, Hall AJ, Curns AT, Parashar UD. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin Infect Dis 2011; 52:466 - 74; http://dx.doi.org/10.1093/cid/ciq163; PMID: 21258098
   PubMed Web of Science ®Google Scholar
• Gastañaduy PA, Hall AJ, Curns AT, Parashar UD, Lopman BA. Burden of norovirus gastroenteritis in the ambulatory setting--United States, 2001-2009. J Infect Dis 2013; 207:1058 - 65; http://dx.doi.org/10.1093/infdis/jis942; PMID: 23300161
   PubMed Web of Science ®Google Scholar
• Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. [Epub ahead of print] Clin Infect Dis 2012; 55:216 - 23; http://dx.doi.org/10.1093/cid/cis386; PMID: 22491338
   PubMed Web of Science ®Google Scholar
• Payne DC, Vinjé J, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA, Hall CB, Chappell J, Bernstein DI, Curns AT, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013; 368:1121 - 30; http://dx.doi.org/10.1056/NEJMsa1206589; PMID: 23514289
   PubMed Web of Science ®Google Scholar
• Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY. The potential economic value of a human norovirus vaccine for the United States. Vaccine 2012; 30:7097 - 104; http://dx.doi.org/10.1016/j.vaccine.2012.09.040; PMID: 23026689
   PubMed Web of Science ®Google Scholar
• Hoffmann S, Batz MB, Morris JG Jr.. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot 2012; 75:1292 - 302; http://dx.doi.org/10.4315/0362-028X.JFP-11-417; PMID: 22980013
   PubMed Web of Science ®Google Scholar
• Johnston CP, Qiu H, Ticehurst JR, Dickson C, Rosenbaum P, Lawson P, Stokes AB, Lowenstein CJ, Kaminsky M, Cosgrove SE, et al. Outbreak management and implications of a nosocomial norovirus outbreak. Clin Infect Dis 2007; 45:534 - 40; http://dx.doi.org/10.1086/520666; PMID: 17682985
   PubMed Web of Science ®Google Scholar
• Fretz R, Schmid D, Jelovcan S, Tschertou R, Krassnitzer E, Schirmer M, Hell M, Allerberger F. An outbreak of norovirus gastroenteritis in an Austrian hospital, winter 2006-2007. Wien Klin Wochenschr 2009; 121:137 - 43; http://dx.doi.org/10.1007/s00508-008-1135-x; PMID: 19280140
   PubMed Web of Science ®Google Scholar
• Zingg W, Colombo C, Jucker T, Bossart W, Ruef C. Impact of an outbreak of norovirus infection on hospital resources. Infect Control Hosp Epidemiol 2005; 26:263 - 7; http://dx.doi.org/10.1086/502537; PMID: 15796278
   PubMed Web of Science ®Google Scholar
• Danial J, Cepeda JA, Cameron F, Cloy K, Wishart D, Templeton KE. Epidemiology and costs associated with norovirus outbreaks in NHS Lothian, Scotland 2007-2009. J Hosp Infect 2011; 79:354 - 8; http://dx.doi.org/10.1016/j.jhin.2011.06.018; PMID: 21955453
   PubMed Web of Science ®Google Scholar
• Lee BY, Wettstein ZS, McGlone SM, Bailey RR, Umscheid CA, Smith KJ, Muder RR. Economic value of norovirus outbreak control measures in healthcare settings. Clin Microbiol Infect 2011; 17:640 - 6; http://dx.doi.org/10.1111/j.1469-0691.2010.03345.x; PMID: 20731684
   PubMed Web of Science ®Google Scholar
• Lee BY, McGlone SM, Bailey RR, Wettstein ZS, Umscheid CA, Muder RR. Economic impact of outbreaks of norovirus infection in hospitals. Infect Control Hosp Epidemiol 2011; 32:191 - 3; http://dx.doi.org/10.1086/657910; PMID: 21460478
   PubMed Web of Science ®Google Scholar
• Hall AJ, Rosenthal M, Gregoricus N, Greene SA, Ferguson J, Henao OL, Vinjé J, Lopman BA, Parashar UD, Widdowson MA. Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004-2005. Emerg Infect Dis 2011; 17:1381 - 8; PMID: 21801613
   PubMed Web of Science ®Google Scholar
• Zintz C, Bok K, Parada E, Barnes-Eley M, Berke T, Staat MA, Azimi P, Jiang X, Matson DO. Prevalence and genetic characterization of caliciviruses among children hospitalized for acute gastroenteritis in the United States. Infect Genet Evol 2005; 5:281 - 90; http://dx.doi.org/10.1016/j.meegid.2004.06.010; PMID: 15737920
   PubMedGoogle Scholar
• Chhabra P, Payne DC, Szilagyi PG, Edwards KM, Staat MA, Shirley SH, Wikswo M, Nix WA, Lu X, Parashar UD, et al. Etiology of viral gastroenteritis in children <5 years of age in the United States, 2008-2009. J Infect Dis 2013; 208:790 - 800; http://dx.doi.org/10.1093/infdis/jit254; PMID: 23757337
   PubMed Web of Science ®Google Scholar
• Podkolzin AT, Fenske EB, Abramycheva NY, Shipulin GA, Sagalova OI, Mazepa VN, Ivanova GN, Semena AV, Tagirova ZG, Alekseeva MN, et al. Hospital-based surveillance of rotavirus and other viral agents of diarrhea in children and adults in Russia, 2005-2007. J Infect Dis 2009; 200:Suppl 1 S228 - 33; http://dx.doi.org/10.1086/605054; PMID: 19817602
   PubMed Web of Science ®Google Scholar
• Lee BY, McGlone SM. Pricing of new vaccines. Hum Vaccin 2010; 6:619 - 26; http://dx.doi.org/10.4161/hv.6.8.11563; PMID: 20861678
   PubMed Web of Science ®Google Scholar
• Riddle MS, Gutierrez RL, Verdu EF, Porter CK. The chronic gastrointestinal consequences associated with campylobacter. Curr Gastroenterol Rep 2012; 14:395 - 405; http://dx.doi.org/10.1007/s11894-012-0278-0; PMID: 22864805
   PubMedGoogle Scholar
• Scallan E, Mahon BE, Hoekstra RM, Griffin PM. Estimates of illnesses, hospitalizations and deaths caused by major bacterial enteric pathogens in young children in the United States. Pediatr Infect Dis J 2013; 32:217 - 21; PMID: 23249909
   PubMed Web of Science ®Google Scholar
• Toljander J, Dovärn A, Andersson Y, Ivarsson S, Lindqvist R. Public health burden due to infections by verocytotoxin-producing Escherichia coli (VTEC) and Campylobacter spp. as estimated by cost of illness and different approaches to model disability-adjusted life years. Scand J Public Health 2012; 40:294 - 302; http://dx.doi.org/10.1177/1403494811435495; PMID: 22312030
   PubMed Web of Science ®Google Scholar
• Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013; 382:209 - 22; http://dx.doi.org/10.1016/S0140-6736(13)60844-2; PMID: 23680352
   PubMed Web of Science ®Google Scholar
• Riddle MS, Tribble DR, Cachafiero SP, Putnam SD, Hooper TI. Development of a travelers’ diarrhea vaccine for the military: how much is an ounce of prevention really worth?. Vaccine 2008; 26:2490 - 502; http://dx.doi.org/10.1016/j.vaccine.2008.03.008; PMID: 18417259
   PubMed Web of Science ®Google Scholar
• Murugaiah C. The burden of cholera. Crit Rev Microbiol 2011; 37:337 - 48; http://dx.doi.org/10.3109/1040841X.2011.603288; PMID: 21823927
   PubMed Web of Science ®Google Scholar
• World Health Organization. Cholera, 2012. Wkly Epidemiol Rec 2013; 88:321 - 34; PMID: 23980290
   PubMedGoogle Scholar
• Sarker AR, Islam Z, Khan IA, Saha A, Chowdhury F, Khan AI, Qadri F, Khan JA. Cost of illness for cholera in a high risk urban area in Bangladesh: an analysis from household perspective. BMC Infect Dis 2013; 13:518; http://dx.doi.org/10.1186/1471-2334-13-518; PMID: 24188717
   PubMed Web of Science ®Google Scholar
• Kirigia JM, Sambo LG, Yokouide A, Soumbey-Alley E, Muthuri LK, Kirigia DG. Economic burden of cholera in the WHO African region. BMC Int Health Hum Rights 2009; 9:8; http://dx.doi.org/10.1186/1472-698X-9-8; PMID: 19405948
   PubMed Web of Science ®Google Scholar
• Poulos C, Riewpaiboon A, Stewart JF, Clemens J, Guh S, Agtini M, Sur D, Islam Z, Lucas M, Whittington D, DOMI Cholera COI Study Group. Costs of illness due to endemic cholera. Epidemiol Infect 2012; 140:500 - 9; http://dx.doi.org/10.1017/S0950268811000513; PMID: 21554781
   PubMed Web of Science ®Google Scholar
• Schaetti C, Weiss MG, Ali SM, Chaignat CL, Khatib AM, Reyburn R, Duintjer Tebbens RJ, Hutubessy R. Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar. PLoS Negl Trop Dis 2012; 6:e1844; http://dx.doi.org/10.1371/journal.pntd.0001844; PMID: 23056660
   PubMed Web of Science ®Google Scholar
• Jeuland M, Cook J, Poulos C, Clemens J, Whittington D, DOMI Cholera Economics Study Group. Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis. Value Health 2009; 12:899 - 908; http://dx.doi.org/10.1111/j.1524-4733.2009.00562.x; PMID: 19824189
   PubMed Web of Science ®Google Scholar
• Maskery B, DeRoeck D, Levin A, Kim YE, Wierzba TF, Clemens JD. Strategy, demand, management, and costs of an international cholera vaccine stockpile. J Infect Dis 2013; 208:Suppl 1 S15 - 22; http://dx.doi.org/10.1093/infdis/jit233; PMID: 24101640
   PubMedGoogle Scholar
• Khan IA, Saha A, Chowdhury F, Khan AI, Uddin MJ, Begum YA, Riaz BK, Islam S, Ali M, Luby SP, et al. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh. Vaccine 2013; 31:6058 - 64; http://dx.doi.org/10.1016/j.vaccine.2013.10.021; PMID: 24161413
   PubMed Web of Science ®Google Scholar
• Dubberke ER, Wertheimer AI. Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol 2009; 30:57 - 66; http://dx.doi.org/10.1086/592981; PMID: 19049438
   PubMed Web of Science ®Google Scholar
• Dubberke E. Clostridium difficile infection: the scope of the problem. J Hosp Med 2012; 7:Suppl 3 S1 - 4; http://dx.doi.org/10.1002/jhm.1916; PMID: 22407993
   PubMedGoogle Scholar
• Depestel DD, Aronoff DM. Epidemiology of Clostridium difficile infection. J Pharm Pract 2013; 26:464 - 75; http://dx.doi.org/10.1177/0897190013499521; PMID: 24064435
   PubMedGoogle Scholar
• Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 2010; 74:309 - 18; http://dx.doi.org/10.1016/j.jhin.2009.10.016; PMID: 20153547
   PubMed Web of Science ®Google Scholar
• McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, Tian Y, Ufberg P, Muder RR, Lee BY. The economic burden of Clostridium difficile.. Clin Microbiol Infect 2012; 18:282 - 9; http://dx.doi.org/10.1111/j.1469-0691.2011.03571.x; PMID: 21668576
   PubMed Web of Science ®Google Scholar
• Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012; 55:Suppl 2 S88 - 92; http://dx.doi.org/10.1093/cid/cis335; PMID: 22752870
   PubMed Web of Science ®Google Scholar
• Tabak YP, Zilberberg MD, Johannes RS, Sun X, McDonald LC. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study. Infect Control Hosp Epidemiol 2013; 34:588 - 96; http://dx.doi.org/10.1086/670621; PMID: 23651889
   PubMed Web of Science ®Google Scholar
• Lee BY, Popovich MJ, Tian Y, Bailey RR, Ufberg PJ, Wiringa AE, Muder RR. The potential value of Clostridium difficile vaccine: an economic computer simulation model. Vaccine 2010; 28:5245 - 53; http://dx.doi.org/10.1016/j.vaccine.2010.05.062; PMID: 20541582
   PubMed Web of Science ®Google Scholar
• Gupta SK, Keck J, Ram PK, Crump JA, Miller MA, Mintz ED. Part III. Analysis of data gaps pertaining to enterotoxigenic Escherichia coli infections in low and medium human development index countries, 1984-2005. Epidemiol Infect 2008; 136:721 - 38; http://dx.doi.org/10.1017/S095026880700934X; PMID: 17686197
   PubMed Web of Science ®Google Scholar
• Lundkvist J, Steffen R, Jönsson B. Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers’ diarrhea. J Travel Med 2009; 16:28 - 34; http://dx.doi.org/10.1111/j.1708-8305.2008.00270.x; PMID: 19192125
   PubMed Web of Science ®Google Scholar
• World Health Organization. Future directions for research on enterotoxigenic Escherichia coli vaccines for developing countries. Wkly Epidemiol Rec 2006; 81:97 - 104; PMID: 16671213
   PubMedGoogle Scholar
• Program for Appropriate Technology in Health (PATH), Bio Ventures for Global Health (BVGH). The case for investment in enterotoxigenic Escherichia coli vaccines. Seattle, WA 2011. Available from: http://www.path.org/publications/files/VAC-etec-investment-rpt.pdf
   Google Scholar
• Grimwood K, Lambert SB, Milne RJ. Rotavirus infections and vaccines: burden of illness and potential impact of vaccination. Paediatr Drugs 2010; 12:235 - 56; http://dx.doi.org/10.2165/11537200-000000000-00000; PMID: 20593908
   PubMedGoogle Scholar
• Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009; 200:Suppl 1 S9 - 15; http://dx.doi.org/10.1086/605025; PMID: 19817620
   PubMed Web of Science ®Google Scholar
• Milne RJ, Grimwood K. Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule. Value Health 2009; 12:888 - 98; http://dx.doi.org/10.1111/j.1524-4733.2009.00534.x; PMID: 19490550
   PubMed Web of Science ®Google Scholar
• Chen K-T, Fan S-F, Tang R-B, Huang YF, Lee PI, Chen PY, Tang CW, Chen HC. Hospital-based study of the economic burden associated with rotavirus diarrhea in Taiwan. Vaccine 2007; 25:4266 - 72; http://dx.doi.org/10.1016/j.vaccine.2007.02.056; PMID: 17360079
   PubMed Web of Science ®Google Scholar
• Chang WC, Yen C, Chi CL, Wu FT, Huang YC, Lin JS, Huang FC, Tate JE, Wu HS, Hsiung CA. Cost-effectiveness of rotavirus vaccination programs in Taiwan. Vaccine 2013; 31:5458 - 65; http://dx.doi.org/10.1016/j.vaccine.2013.08.103; PMID: 24060569
   PubMed Web of Science ®Google Scholar
• Tate JE, Rheingans RD, O’Reilly CE, Obonyo B, Burton DC, Tornheim JA, Adazu K, Jaron P, Ochieng B, Kerin T, et al. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya. J Infect Dis 2009; 200:Suppl 1 S76 - 84; http://dx.doi.org/10.1086/605058; PMID: 19817618
   PubMed Web of Science ®Google Scholar
• Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho H, Glass RI, Bresee JS. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 2005; 192:1720 - 6; http://dx.doi.org/10.1086/497339; PMID: 16235169
   PubMed Web of Science ®Google Scholar
• Flem ET, Latipov R, Nurmatov ZS, Xue Y, Kasymbekova KT, Rheingans RD. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan. J Infect Dis 2009; 200:Suppl 1 S195 - 202; http://dx.doi.org/10.1086/605040; PMID: 19817600
   PubMedGoogle Scholar
• Smith ER, Rowlinson EE, Iniguez V, Etienne KA, Rivera R, Mamani N, Rheingans R, Patzi M, Halkyer P, Leon JS. Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective. Vaccine 2011; 29:6704 - 11; http://dx.doi.org/10.1016/j.vaccine.2011.05.038; PMID: 21624421
   PubMed Web of Science ®Google Scholar
• Takemoto MLS, Bahia L, Toscano CM, Araujo DV. Systematic review of studies on rotavirus disease cost-of-illness and productivity loss in Latin America and the Caribbean. Vaccine 2013; 31:Suppl 3 C45 - 57; http://dx.doi.org/10.1016/j.vaccine.2013.05.031; PMID: 23777691
   PubMedGoogle Scholar
• Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 2007; 119:684 - 97; http://dx.doi.org/10.1542/peds.2006-2876; PMID: 17403839
   PubMed Web of Science ®Google Scholar
• Cortes JE, Curns AT, Tate JE, Cortese MM, Patel MM, Zhou F, Parashar UD. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med 2011; 365:1108 - 17; http://dx.doi.org/10.1056/NEJMoa1000446; PMID: 21992123
   PubMed Web of Science ®Google Scholar
• Coyle D, Coyle K, Bettinger JA, Halperin SA, Vaudry W, Scheifele DW, Le Saux N. Cost effectiveness of infant vaccination for rotavirus in Canada. Can J Infect Dis Med Microbiol 2012; 23:71 - 7; PMID: 23730312
   PubMed Web of Science ®Google Scholar
• Fisman DN, Chan CH, Lowcock E, Naus M, Lee V. Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation. Vaccine 2012; 30:7601 - 7; http://dx.doi.org/10.1016/j.vaccine.2012.10.034; PMID: 23107595
   PubMed Web of Science ®Google Scholar
• Atkins KE, Shim E, Carroll S, Quilici S, Galvani AP. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Vaccine 2012; 30:6766 - 76; http://dx.doi.org/10.1016/j.vaccine.2012.09.025; PMID: 23000223
   PubMed Web of Science ®Google Scholar
• Tu HAT, Rozenbaum MH, de Boer PT, Noort AC, Postma MJ. An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”. BMC Infect Dis 2013; 13:54; http://dx.doi.org/10.1186/1471-2334-13-54; PMID: 23363553
   PubMed Web of Science ®Google Scholar
• Bruijning-Verhagen P, Mangen M-JJ, Felderhof M, Hartwig NG, van Houten M, Winkel L, de Waal WJ, Bonten MJ. Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination. BMC Med 2013; 11:112; http://dx.doi.org/10.1186/1741-7015-11-112; PMID: 23622110
   PubMed Web of Science ®Google Scholar
• Diez-Domingo J, Suriñach NL, Alcalde NM, Betegón L, Largeron N, Trichard M. Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain. BMC Public Health 2010; 10:469; http://dx.doi.org/10.1186/1471-2458-10-469; PMID: 20698958
   PubMed Web of Science ®Google Scholar
• van Hoek AJ, Ngama M, Ismail A, Chuma J, Cheburet S, Mutonga D, Kamau T, Nokes DJ. A cost effectiveness and capacity analysis for the introduction of universal rotavirus vaccination in Kenya: comparison between Rotarix and RotaTeq vaccines. PLoS One 2012; 7:e47511; http://dx.doi.org/10.1371/journal.pone.0047511; PMID: 23115650
   PubMed Web of Science ®Google Scholar
• Liu N, Yen C, Fang ZY, Tate JE, Jiang B, Parashar UD, Zeng G, Duan ZJ. Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China. Vaccine 2012; 30:6940 - 5; http://dx.doi.org/10.1016/j.vaccine.2012.05.084; PMID: 22705174
   PubMed Web of Science ®Google Scholar
• Suwantika AA, Tu HAT, Postma MJ. Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account. Vaccine 2013; 31:3300 - 7; http://dx.doi.org/10.1016/j.vaccine.2013.04.055; PMID: 23707163
   PubMed Web of Science ®Google Scholar
• Atherly DE, Lewis KDC, Tate J, Parashar UD, Rheingans RD. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030. Vaccine 2012; 30:Suppl 1 A7 - 14; http://dx.doi.org/10.1016/j.vaccine.2011.12.096; PMID: 22520139
   PubMed Web of Science ®Google Scholar
• Tu HA, Woerdenbag HJ, Kane S, Rozenbaum MH, Li SC, Postma MJ. Economic evaluations of rotavirus immunization for developing countries: a review of the literature. Expert Rev Vaccines 2011; 10:1037 - 51; http://dx.doi.org/10.1586/erv.11.65; PMID: 21806398
   PubMed Web of Science ®Google Scholar
• Verguet S, Murphy S, Anderson B, Johansson KA, Glass R, Rheingans R. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis. Vaccine 2013; 31:4902 - 10; http://dx.doi.org/10.1016/j.vaccine.2013.07.014; PMID: 23871824
   PubMed Web of Science ®Google Scholar
• Kotsopoulos N, Connolly MP, Postma MJ, Hutubessy RC. Fiscal consequences of changes in morbidity and mortality attributed to rotavirus immunisation. Vaccine 2013; 31:5430 - 4; http://dx.doi.org/10.1016/j.vaccine.2013.09.002; PMID: 24055088
   PubMed Web of Science ®Google Scholar
• von Seidlein L, Kim DR, Ali M, Lee H, Wang X, Thiem VD, Canh G, Chaicumpa W, Agtini MD, Hossain A, et al. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med 2006; 3:e353; http://dx.doi.org/10.1371/journal.pmed.0030353; PMID: 16968124
   PubMed Web of Science ®Google Scholar
• Riewpaiboon A, Youngkong S, Sreshthaputra N, Stewart JF, Samosornsuk S, Chaicumpa W, von Seidlein L, Clemens JD. A cost function analysis of shigellosis in Thailand. Value Health 2008; 11:Suppl 1 S75 - 83; http://dx.doi.org/10.1111/j.1524-4733.2008.00370.x; PMID: 18387071
   PubMedGoogle Scholar
• Ziv T, Heymann AD, Azuri J, Leshno M, Cohen D. Assessment of the underestimation of childhood diarrhoeal disease burden in Israel. Epidemiol Infect 2011; 139:1379 - 87; http://dx.doi.org/10.1017/S0950268810002554; PMID: 21087537
   PubMed Web of Science ®Google Scholar
• Gargouri N, Walke H, Belbeisi A, Hadadin A, Salah S, Ellis A, Braam HP, Angulo FJ. Estimated burden of human Salmonella, Shigella, and Brucella infections in Jordan, 2003-2004. Foodborne Pathog Dis 2009; 6:481 - 6; http://dx.doi.org/10.1089/fpd.2008.0192; PMID: 19415972
   PubMed Web of Science ®Google Scholar
• Rolfo F, Marin GH, Silberman M, Pattin J, Giugnio S, Gatti B, Bettiol M, Rigoni A. Epidemiological study of shigellosis in an urban area of Argentina. J Infect Dev Ctries 2012; 6:324 - 8; PMID: 22505441
   PubMed Web of Science ®Google Scholar
• Arvelo W, Blum LS, Nahar N, von Seidlein L, Nahar L, Pack RP, Brooks AW, Pach A, Breiman RF, Luby SP, et al. Community perceptions of bloody diarrhoea in an urban slum in South Asia: implications for introduction of a Shigella vaccine. Epidemiol Infect 2011; 139:599 - 605; http://dx.doi.org/10.1017/S0950268810001391; PMID: 20546637
   PubMedGoogle Scholar
• Fletcher SM, Stark D, Harkness J, Ellis J. Enteric protozoa in the developed world: a public health perspective. Clin Microbiol Rev 2012; 25:420 - 49; http://dx.doi.org/10.1128/CMR.05038-11; PMID: 22763633
   PubMed Web of Science ®Google Scholar
• Nelson EAS, de Quadros CA, Santosham M, Parashar UD, Steele D. Overcoming perceptions of financial barriers to rotavirus vaccine introduction in Asia. Hum Vaccin Immunother 2013; 9:1 - 9; http://dx.doi.org/10.4161/hv.26107; PMID: 23955246
   PubMed Web of Science ®Google Scholar
• DeRoeck D, Clemens JD, Nyamete A, Mahoney RT. Policymakers’ views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine 2005; 23:2762 - 74; http://dx.doi.org/10.1016/j.vaccine.2004.11.044; PMID: 15780724
   PubMed Web of Science ®Google Scholar
• Lee BY, Assi TM, Rajgopal J, Norman BA, Chen SI, Brown ST, Slayton RB, Kone S, Kenea H, Welling JS, et al. Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger. Am J Public Health 2012; 102:269 - 76; http://dx.doi.org/10.2105/AJPH.2011.300218; PMID: 21940923
   PubMed Web of Science ®Google Scholar
• Lee BY, Assi T-M, Rookkapan K, Wateska AR, Rajgopal J, Sornsrivichai V, Chen SI, Brown ST, Welling J, Norman BA, et al. Maintaining vaccine delivery following the introduction of the rotavirus and pneumococcal vaccines in Thailand. PLoS One 2011; 6:e24673; http://dx.doi.org/10.1371/journal.pone.0024673; PMID: 21931805
   PubMed Web of Science ®Google Scholar
• Haidari LA, Connor DL, Wateska AR, Brown ST, Mueller LE, Norman BA, Schmitz MM, Paul P, Rajgopal J, Welling JS, et al. Augmenting transport versus increasing cold storage to improve vaccine supply chains. PLoS One 2013; 8:e64303; http://dx.doi.org/10.1371/journal.pone.0064303; PMID: 23717590
   PubMed Web of Science ®Google Scholar